ナトリウムジルコニウムサイクロシリケートに関連した有害事象: FAERSデータベースに基づいた現実世界の医薬品警戒調査
Yinrui Fang1,2, Zilun Wu1,2, Qian Wu1,2
1Guangzhou University of Chinese Medicine, Guangzhou, China.
PloS one
|September 2, 2025
まとめ
塩酸ジルコニウムサイクロシリケート (SZC) は高カリミアの治療法である. 低血量症や心臓病などの早期の有害事象が 現れており 新しい信号も出ています
科学分野:
- 薬用警戒について
- 腎臓科
- 心臓病科
背景:
- Sodium zirconium cyclosilicate (SZC,Lokelma) は,高カリミアに対する新しい治療法である.
- SZCに関する包括的な現実世界の安全性データは限られている.
- 薬物の安全性プロフィールを特徴づけるには,マーケティング後の監視が不可欠です.
研究 の 目的:
- 塩酸ジルコニウムサイクロシリケート (SZC) と関連した有害事象 (AE) を特徴づける.
- 販売後の監視データを用いて,潜在的な安全性信号を特定する.
- ハイパーカリミアの管理におけるSZCの実際の安全性を評価する.
主な方法:
- FDAの有害事象報告システム (FAERS) (2004-2023) からSZC/ロケルマの有害事象報告を抽出した.
- 4つの不釣り合いのアルゴリズム (ROR,PRR,BCPNN,MGPS) を使用して安全信号を特定した.
- 重要なシステム・オルガン・クラス (SOC) と好ましい期限 (PT) 信号に対する厳格な基準を適用し,誤った発見率の調整を含む.
主要な成果:
- 1,564のAE報告を分析し,代謝/栄養,腎臓/尿路,心臓,および一般的な障害のSOCを特定した.
- 18のPTシグナルには,低血量症,心不全,高血圧が含まれていた.
- AEsは治療初期に集中 (30日以内の41. 87%) され,サブグループ分析により信号の強度が確認された.
結論:
- Sodium zirconium cyclosilicate (SZC) は,特に治療の初期に,既知の有害事象と潜在的に新しい有害事象の両方に関連しています.
- 臨床医は,SZCの初期治療中に代謝,腎臓,心臓の有害事象を注意深く観察することを検討する必要があります.
- 将来の研究で早期の安全性信号のさらなる検証が必要であり,長期的なリスクについては明確化が必要である.
さらに関連する動画
14:20High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
6.0K
09:46Adsorption Device Based on a Langatate Crystal Microbalance for High Temperature High Pressure Gas Adsorption in Zeolite H-ZSM-5
Published on: August 25, 2016
11.8K
関連する概念動画
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
Local Anesthetics: Adverse Effects
491
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
491
Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
